DocWire News Editors

DocwireNews

There exists a higher rate of multiple myeloma (MM) progression in younger patients with smoldering multiple myeloma (SMM) patients than old ones as well as an earlier age of SMM diagnosis in Black patients compared to White patients, according to a study presented at the 17th International Myeloma Workshop.SMM is the asymptomatic phase before MM, and until recently observation has been the standard protocol of care. However, enhancements in risk assessment and chemoprevention strategies is starting to yield enhanced early detection results.In this study, researchers sought to characterize the demographics and dynamics of SMM patients. They analyzed data from the National Cancer Data Base (NCDB) between the year 2010 and 2014, and identified 68,234 patients, of which 11,643 had SMM (52% male, 71% white, 24% black). SMM was defined as patients that were placed on active surveillance or did not receive therapy in the first three months following diagnosis. They estimated the impact of medical insurance on overall survival using the Cox model, adjusting for confounders such as age, sex, race, tumor, and Charlson score.According to the results, SMM was diagnosed in Blacks at an average age of 66, four years earlier compared to Whites, with an overall rate of progression of 21%. Subsequent to controlling for insurance, age and transplant effects, race was deemed insignificant in predicting the time from diagnosis of SMM to first therapy. Moreover, the study found that younger patients were more likely to receive therapy first. Researchers further observed that survival after starting therapy in SMM patients who progressed to MM was same for both races, but overall survival was higher in patients with private insurance plans.The authors wrote that their findings highlight &ldquo;the importance of known SMM stage before MM in prolonging survival which can be indicative of benefit from screening programs.&rdquo;Vuyyala S, et al. Risk of Progression Across Age and Race for Patients with Smoldering Multiple Myeloma. Presented at the 17th International Myeloma Workshop; September 12-15, 2019; Boston, MA.

MarkAlain Déry, DO

The Significant Danger Measles Pose for Unvaccinated Children

Infectious Disease

Andrew Moreno

Antithrombotic Care in Hemophilia: A Summary of Multi-Organizational Clinical Practice Guidance

Hemophilia

James Tumlin, MD

Joel M. Topf, MD, FACP

Proteinuria Remission With Sparsentan in FSGS

NKF Spring Clinical Meetings 2025

Latest News

Risk of Progression Across Age and Race for Patients with Smoldering Multiple Myeloma

International Myeloma Workshop 2019

There exists a higher rate of multiple myeloma (MM) progression in younger patients with smoldering multiple myeloma patients than old ones. 

About Us

Editorial Policy

Advertising

Contact Us

eNewsletters

Contribute

Career Center

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Bile Duct Cancer

Colorectal Cancer

Gastroesophageal Cancer

Gastric Cancer

GEP-NETs

GIST

Liver Cancer

Pancreatic Cancer

GI Oncology Now

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Sickle Cell Disease

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

Acute Kidney Injury

ADPKD

Anemia and Kidney Disease

Chronic Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

End-Stage Renal Disease

Gout

Hyperkalemia

IgAN

Kidney Transplantation

Metabolic Acidosis

Nephrology Times

HER2 Breast Cancer

HR Breast Cancer

Triple-Negative Breast Cancer

Genetics & Breast Cancer

Breast Cancers Today

Atherosclerotic Disease

Atrial Fibrillation

Heart Failure

Hypertension

Interventional Cardiology

Lipid Management

Practice Tips With Dr. Lichaa

Preventive Cardiology

Stroke

Cardiology

Breast Cancer

Gynecologic Cancer

Head and Neck Cancer

Skin Cancer

Oncology

Sleep

Urology

Diabetes

Ophthalmology

— Demodex Blepharitis

Neurology

Rheumatology

Gastroenterology

Pulmonology

Infectious Diseases

— HIV

Health and Wellness

Lupus

Future of Medicine

Orthopedics

Pharmacology

Career News

More

Conferences

CardioNerds

The Sleep Source With Dr. Morse

Rheumatology Rounds With Dr. Maheswaranathan

Partners

Expert Interviews

Subscribe